2 active not recruiting, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 2, Recruiting 1 |
Follow Trontinemab: new trials by email Literature Review of Trontinemab trials Research Report on Trontinemab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease Trontinemab, Placebo - Alzheimer's Disease | Phase 3 | Recruiting | Hoffmann-La Roche | 1600 | 2026-10-02 | 2026-11-06 |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease Trontinemab, Placebo - Alzheimers Disease | Phase 3 | Active not recruiting | Hoffmann-La Roche | 1060 | 2025-11-12 | 2026-09-25 |
| A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease Trontinemab, Placebo - Alzheimers Disease | Phase 3 | Active not recruiting | Hoffmann-La Roche | 1101 | 2025-09-17 | 2026-09-25 |
Alzheimer Disease (3) · Cognitive Dysfunction (2)
Argentina (3) · Brazil (3) · Canada (3) · Japan (3) · United Kingdom (3) · United States (3) · Australia (2) · China (2) · France (2) · Germany (2) · Italy (2) · Poland (2) · Spain (2) · Taiwan (2) · Chile (1)